Please assess the completion status of the following clinical trial:

Trial Title: A Safety And Efficacy Study of Ibuprofen 250 mg / Acetaminophen 500 mg In The Treatment Of Post-Surgical Dental Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Outpatients who have undergone surgical extraction of 3 or more third molars, of which at least 2 must be a partial or complete bony mandibular impaction.~* Subject must have at least moderate pain on the 4-point categorical scale, confirmed by at least 50 mm on the 100 mm VAS PSR scale within approximately 5 hours (i.e., less than or equal to 5 hours, 15 minutes) after surgery is completed.~* Female subjects are not pregnant or breast feeding.~* Informed consent.~Exclusion Criteria:~* Presence or history of any significant hepatic, renal, endocrine, cardiovascular, neurological, psychiatric, gastrointestinal, pulmonary, hematologic, or metabolic disorder determined by the Investigator to place the subject at increased risk, including the presence or history within 2 years of screening.~* Acute localized dental alveolar infection at the time of surgery that could confound the post-surgical evaluation.~* Hypersensitivity to ibuprofen, naproxen, aspirin, or any other NSAID; or to APAP, tramadol, other opioids, or to their combinations.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Ibuprofen 250 mg / Acetaminophen 500 mg (Type: EXPERIMENTAL): 2 caplets of Ibuprofen 125 mg / Acetaminophen 250 mg
- Ibuprofen 250 mg (Type: ACTIVE_COMPARATOR): 2 caplets of IBU 125 mg
- Acetaminophen 650 mg (Type: ACTIVE_COMPARATOR): 2 tablets of APAP 325 mg
- Placebo (Type: ACTIVE_COMPARATOR): 2 caplets of Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).